TOFASURE 5 TABLET is used to manage inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis. TOFASURE 5 TABLET is also used to manage polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis, which cause pain and inflammation of joints in children.
TOFASURE 5 TABLET contains Tofacitinib, which belongs to the group of medicines called Antirheumatics. It prevents the body from responding to these substances called cytokines (which control the growth and activity of other immune system cells and blood cells). It also inhibits the inflammation process via a new pathway (Janus kinases).
TOFASURE 5 TABLET is used alone or together with other drugs, such as methotrexate. Take TOFASURE 5 TABLET as advised by your physician. Swallow the medicine with a glass of water. It can also be crushed and taken with water. Do not chew the medicine.
TOFASURE 5 TABLET is not recommended for use in patients with severe liver diseases (including cirrhosis), bloodstream infections, or active tuberculosis. TOFASURE 5 TABLET should be used with caution in patients who have an infection or a condition that increases their risk of infection (for example, diabetes, HIV/AIDS, or a weak immune system), chronic lung disease, tuberculosis, hepatitis B or C, liver, kidney, or heart diseases, cancer or are at risk of developing skin cancer, smoking habits, lactose intolerance, inflammation of the large intestine, stomach or intestine ulcers, blood pressure, high cholesterol, or are at risk of developing a blood clot, are planning to get vaccinated, or have undergone major surgery.
TOFASURE 5 TABLET should not be used by pregnant or breastfeeding women. TOFASURE 5 TABLET should be used with caution in patients over the age of 65. The safety and effectiveness of TOFASURE 5 TABLET in children under the age of two have not yet been established.
Lung infection, sore throat, sinusitis, vomiting, nausea, diarrhea,...
No content available
